Global /India /Healthcare /Drug Manufacturers - General /WINDLAS
chevron_leftBack
Windlas Biotech Ltd. logo

Windlas Biotech Ltd.

WINDLAS
NSE: WINDLAS Delayed
851.85INR 0.1%
9.02 USD
As of 20 June 2026, Windlas Biotech Ltd. has a market cap of $189.97M USD, ranking #21411 globally and #1239 in India. It ranks #1910 in the Healthcare sector, and #691 in the Drug Manufacturers - General industry.
Global Rank
21411
Country Rank
1239
Sector Rank
1910
Industry Rank
691
Key Stats
Market Cap
$189.97MUSD
17.93B INR
Enterprise Value
$165.61MUSD
15.64B INR
Revenue (TTM)
$91.99MUSD
8.68B INR
EBITDA (TTM)
$11.49MUSD
1.09B INR
Net Income (TTM)
$7.07MUSD
667.47M INR
EBITDA Margin
12%
Profit Margin
7.7%
PE Ratio
27.1
PS Ratio
2.1
PB Ratio
3.4
EV/EBITDA
14.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Komal Gupta open_in_new
Employees
1,346
Founded
2001
Website
windlas.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.1% -3.7% 11% 8% -8.5% -14%

News

Loading...

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
WINDLAS
Windlas Biotech Ltd
ISIN: INE0H5O01029
Shares Out.:
21.166M1 Shares Float: 7.827M2
TV:
SA:
YF:
GF:
BA:
MS:
851.85 INR
Bombay Stock Exchange
MIC: XBOM
543329 (WINDLAS)
Windlas Biotech Ltd
ISIN: INE0H5O01029
TV:
SA:
YF:
GF:
BA:
MS:
852.30 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Windlas Biotech Ltd.

Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India. The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services. It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable and dispersible tablets, customized generics, and complex generics and multi-drug combinations, as well as injectables, including liquid vials, lyophilized vials, and ampoules. In addition, the company offers generic drugs for respiratory, anti-diabetic, gastroenterology, cardiovascular and multivitamin, neuro anti-psychotic, diabetic care, nutraceuticals, nutritional supplement, urology, pain management, and injectable therapies. It also exports generic medicines, health supplements, and custom-branded formulations. Windlas Biotech Limited was incorporated in 2001 and is headquartered in Dehradun, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
24K%
39.1
DIVISLAB
$18.38B
1.73T INR
10K%
70.0
$15.17B
1.43T INR
8K%
63.0
$11.73B
1.11T INR
6K%
19.6
MANKIND
$9.87B
931.67B INR
5K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
5K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
401K%
38.1
JNJ
$547.28B
288K%
26.4
ABBV
$360.63B
190K%
97.4
$318.3B
256.25B CHF
167K%
19.9
AZN
$284.64B
215.59B GBP
150K%
27.6
MRK
$274.03B
144K%
15.1
chevron_leftBack